You are here:
Home
NICE Guidance
Conditions and diseases
Cancer
Breast cancer
Trastuzumab deruxtecan with or without pertuzumab for untreated HER2-positive metastatic breast cancer [ID6548]
Topic selection
Project information
Project documents
34271-Trastuzumab-Deruxtecan-Pertuzumab-for-Breast-Cancer-V1.0-DEC2024-NON-CONF.pdf
Back to top